Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity. (Q38849522)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Glaucia Regina Martinez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Carina T Scoparo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Paulo R Worfel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Fernanda A L B Guterres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sheila M B Winnischofer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Attilio Di Pietro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Maria E M Rocha

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

26 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

123-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

Estimating the world cancer burden: Globocan 2000.

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hepatocellular carcinoma: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Chemoprevention of liver cancer by plant polyphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hepatocellular carcinoma and hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Molecular pathways in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Molecular bases of liver cancer refractoriness to pharmacological treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Flavonoids: Promising anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Flavonoids as RTK inhibitors and potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hispidulin sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by AMPK activation leading to Mcl-1 block in translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hispidulin: antioxidant properties and effect on mitochondrial energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Increased biliary glutathione disulfide release in chronically ethanol-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Apigenin: a promising molecule for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2518-8

The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan

21 January 2018

1 reference

12 December 2020

Quantification of cells cultured on 96-well plates

1 reference

12 December 2020

Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells

1 reference

12 December 2020

Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

1 reference

12 December 2020

The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase

1 reference

12 December 2020

MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications

1 reference

12 December 2020

Flavone induces cell death in human hepatoma HepG2 cells.

1 reference

12 December 2020

Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method

1 reference

12 December 2020

Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer

1 reference

12 December 2020

Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation

1 reference

12 December 2020

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

12 December 2020

10.1007/S11010-015-2518-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26209062%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 February 2020

1007500447

0 references

Fatcat ID

release_mjzhym555ncdxcvppa74hxhwze

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mjzhym555ncdxcvppa74hxhwze

24 November 2022

mapped directly with Wikidata item

1 reference